Comparison of Miglitol and Acarbose in Japanese patient with type 2 diabetes by using continuous glucose monitoring (CGM)

Comparison of Miglitol and Acarbose in Japanese patient with type 2 diabetes by using continuous glucose monitoring (CGM) - MAJOR study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001202

Enrollment

Registered

2008-06-19

Start date

2008-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

Miglitol Acarbose

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 diabetes. 6.0%<HbA1c<8.0%.

Exclusion criteria

Exclusion criteria: Type 1 diabetes. Patients receiving insulin therapy. Severe liver dysfunction. Severe renal dysfunction.

Design outcomes

Primary

Measure	Time frame
The outcome of postprandial glucose control by CGM	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026